Milestone Healthcare

Imatinib, sold under the brand names Levin 400mg among others, is a medication used to treat cancer.Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph⁺), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome(HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis, and myelodysplastic syndrome It is taken by mouth

DASATRUE is indicated for the treatment of • Adults with chronic, accelerated or myeloid or lymphoid blast Phase chronic myeloid leukaemia (CML). • Newly diagnosed adults with CML in chronic phase. • Paediatric patients with Philadelphia chromosome positive CML (ph+ CML) in chronic phase.

IMATIB 400MG TABLET contains Imatinib which belongs to the group of medicines called Tyrosine Kinase Inhibitors. It is used in adults, children and adolescents to treat chronic myeloid leukaemia (CML) (a form of leukaemia in which certain abnormal white cells (named myeloid cells) start growing out of control) and philadelphia chromosome positive acute lymphoblastic leukaemia (Ph-positive ALL) (a form of leukaemia in which certain abnormal white cells (named lymphoblasts) start growing out of control).

Also, it is used in adults only to treat myelodysplastic/myeloproliferative diseases (MDS/MPD) (a group of blood diseases in which some blood cells start growing out of control), hyper eosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) (a blood diseases in which some blood cells (named eosinophils) start growing out of control), gastrointestinal stromal tumours (GIST) (cancer of the stomach and bowels) and dermatofibrosarcoma protuberans (DFSP) (cancer of the tissue beneath the skin in which some cells start growing out of control).

IMATINB 400MG TABLET contains Imatinib which belongs to the group of medicines called Tyrosine Kinase Inhibitors. It is used in adults, children and adolescents to treat chronic myeloid leukaemia (CML) (a form of leukaemia in which certain abnormal white cells (named myeloid cells) start growing out of control) and philadelphia chromosome positive acute lymphoblastic leukaemia (Ph-positive ALL) (a form of leukaemia in which certain abnormal white cells (named lymphoblasts) start growing out of control).

Also, it is used in adults only to treat myelodysplastic/myeloproliferative diseases (MDS/MPD) (a group of blood diseases in which some blood cells start growing out of control), hyper eosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) (a blood diseases in which some blood cells (named eosinophils) start growing out of control), gastrointestinal stromal tumours (GIST) (cancer of the stomach and bowels) and dermatofibrosarcoma protuberans (DFSP) (cancer of the tissue beneath the skin in which some cells start growing out of control).

Lenavatinib Capsules 4 mg
Established in the year 2011 at Vadodara (Gujarat, India), “Milestone Healthcare” are a Sole Proprietorship firm engaged in wholesaling, trading and exporting an excellent quality range of Pharmaceutical Tablet and Pharmaceutical Injection. These pharma products are sourced from reliable market vendors and can be availed by our clients at reasonable prices. Under the guidance of “Mr. Gitesh Jaiswal”,

Enzalutamide is used to treat prostate cancer. This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer.

Sorafenib is indicated for the treatment of: • Patients with advanced renal cell carcinoma • Hepatocellular carcinoma • Patients with locally advanced or metastatic, differentiated thyroid carcinoma, refractory to radioactive iodine

• Cabotres Tablets is indicated for the treatment of advanced renal cell carcinoma (RCC): - in treatment-naïve adults with intermediate or poor risk in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy klevatocellular Carcinoma (I-ICC) • Cabortres Tablet is indicated as monotherapy for the treatment of hepatocellular carcinoma (HCC) in adults who have previously been treated with sorafenib.

DOSAGE FORM & STRENGTH: 250 mg tablets for oral use CLINICAL PARTICULARS: GEFTICIP Tablets are indicated as mono therapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSLC) of the failure of both platinum-based docetaxel chemo therapies. Posology & method of administration Treatment with GEFTICIP Tablets should be initiated and supervised by a physician the of anti-cancer therapies.

SORAFENIB 200MG TABLET contains Sorafenib which belongs to the group of medicines called Multikinase inhibitors. It is used to treat liver cancer, and kidney cancer  at an advanced stage when standard therapy has not helped to stop the disease or considered unsuitable. SORAFENIB 200MG TABLET is also used to treat differentiated thyroid cancer that is not responding to radioactive iodine treatment.

USES OF SORAFENIB 200MG TABLET

• Treats liver cancer (hepatocellular carcinoma)
• Treats kidney cancer (advanced renal cell carcinoma)
• Treats thyroid cancer (differentiated thyroid carcinoma)

Capecitabine is a fluoropyrimidine carbamate with antineoplastic activity. It is an orally administered systemic prodrug of 5'-deoxy-5-fluorouridine (5'-DFUR) which is converted to 5- fluorouracil. The chemical name for Capecitabine is 5'-deoxy-5-fluoro-N-Rpentyloxy) carbonyl]-cytidine and has a molecular weight of 359.35. INDICATIONS Breast Cancer: For treatment of patients with locally advanced or metastatic breast cancer after failure of paclitaxel and an anthracycline containing chemotherapy regimen. Colorectal Cancer: As first line treatment in patients with metastatic colorectal carcinoma.

Used for anti cancer medications

Eltrombopag 25mg Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia. 

Eltrombopag 25mg Tablet is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. It is also used to treat severe aplastic anemia. Eltrombopag25mg Tablet is used to increase the number of platelets (cells that help the blood clot) to decrease the risk of bleeding in adults and children 1 year of age and older who have chronic idiopathic thrombocytopenic purpura (ITP, an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood). It is used in patients who have not benefited or cannot be treated with other treatments, including medications or surgery to remove the spleen.